Previous close | 0.0450 |
Open | 0.0400 |
Bid | 0.0400 x N/A |
Ask | 0.0450 x N/A |
Day's range | 0.0400 - 0.0400 |
52-week range | 0.0300 - 0.1300 |
Volume | |
Avg. volume | 38,412 |
Market cap | 3.484M |
Beta (5Y monthly) | -1.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0800 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Jack Nathan Medical ( CVE:JNH ) Full Year 2024 Results Key Financial Results Revenue: CA$19.1m (up 24% from FY 2023...
TORONTO, April 29, 2024--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2024, and fiscal year ended January 31, 2024. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, December 12, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2024, nine months ended October 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").